Day: March 6, 2025

Strategic Investment in Its Best Properties is Key Aspect of Macerich’s Path Forward PlanA Media Snippet accompanying this announcement is available by clicking on this link. SANTA MONICA, Calif., March 06, 2025 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced that Pindustry will anchor HiFi, its mixed-use outdoor development project adjacent to premier retail destination FlatIron Crossing. HiFi at FlatIron Crossing, Macerich’s thriving property in Colorado’s busy Denver-Boulder corridor, blends multifamily living, unique shopping, dining and entertainment with lush green spaces to create a new destination for all things fun. Pindustry – a two-level, locally owned entertainment destination – will join NOVEL FlatIron...

Viasat and its ecosystem partners GuardianSat, Quectel, and Acceleronix, successfully complete trial in Brazil to showcase direct-to-device connectivity for the automotive industryViasat and partners deliver first-of-its-kind direct-to-device demonstration in South AmericaViasat and its ecosystem partners GuardianSat, Quectel, and Acceleronix, successfully complete trial in Brazil to showcase direct-to-device connectivity for the automotive industryCARLSBAD, Calif., March 06, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced the first-of-its-kind demonstration of direct-to-device (D2D) connectivity for the automotive sector — opening the door for widescale adoption of satellite connectivity for automotive use cases. In a country-first, the tests saw different...

FREDERICK, Md., March 06, 2025 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of an inducement award to one new employee. On March 3, 2025, the Company issued to this employee an option to purchase 2,650 shares of the Company’s common stock with an exercise price of $17.50, the closing trading price of the Company’s common stock on the Nasdaq Global Market on the date of grant. The option was granted pursuant to the Company’s Amended and Restated 2018 Employment Inducement Incentive Award Plan and was approved by the Company’s board of directors. The option vests as to 25% on March 3, 2026, and then in three equal annual installments thereafter such that the...

– CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD – – Flexible Dosing and Extended Duration would be Important Differentiators from Existing Approved Therapies and Other Tyrosine Kinase Inhibitors in Development – ALPHARETTA, Ga., March 06, 2025 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today the receipt of the formal meeting minutes from its recent End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) relating to CLS-AX (axitinib injectable suspension) for the treatment of neovascular age-related macular degeneration (wet AMD). CLS-AX combines the flexible dosing of...

Vopak announces change in the composition of the Supervisory Board Rotterdam, the Netherlands, 6th March 2025 Vopak announces that Lucrèce Foufopoulos – De Ridder has decided to step down as member of the Supervisory Board of Vopak as per the Annual General Meeting to be held on 23 April 2025, following her decision to accept another board position. The Supervisory Board and the Executive Board would like to thank Lucrèce Foufopoulos – De Ridder for her contribution to Vopak during her tenure. The Supervisory Board is in the process to find a replacement for the vacant position in the Supervisory Board. This press release contains inside information as meant in clause 7 of the Market Abuse Regulation. About Royal VopakRoyal Vopak helps the world flow forward. At ports around the world, we provide storage and infrastructure...

Company to host conference call and webcast on Thursday, March 27th at 8:30am EDT AUSTIN, Texas, March 6, 2025 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2024, before the markets open on Thursday, March 27th, 2025. An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration. Call Details: Date:                Thursday, March 27th Time:                 8:30 am EDT Domestic:        1-800-225-9448 International:    1-203-518-9708 Passcode:        EDAP Webcast:...

VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its wholly owned subsidiary Algernon NeuroScience (AGN Neuro), has appointed Netcapital Securities Inc. (“Netcapital Securities”), a FINRA-registered broker-dealer, for its planned Regulation A (Reg A) offering. Netcapital plans to provide broker-dealer and administrative services, excluding underwriting and placement agent services, in connection with this offering. AGN Neuro has filed a Form 1-A with the U.S. Securities and Exchange Commission (SEC), though the offering has not yet been qualified or declared effective by the SEC. AGN Neuro intends to use proceeds from the...

Company is strategically positioned following the recent $20 million capital raise, enhancing manufacturing capabilities to accelerate qualification and shipments under existing agreements NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) — Dear Fellow Shareholders, As we reflect on the progress since our December update, I am excited to share the latest developments that will shape our Company’s trajectory in 2025 and beyond. With the successful closing of a $20 million financing in January, we strengthened our balance sheet by securing working capital for operating and capital expenditures and paid down our debt to zero. We believe that we are now well-positioned to advance our operations in Hungary through the previously announced SoloGard and SecureGard agreements, alongside ongoing business development initiatives in the U.S. We...

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) — G-III Apparel Group, Ltd. (NASDAQ: GIII) a global fashion leader with expertise in design, sourcing, and marketing, today announced that it will release its fourth quarter and full year fiscal 2025 earnings before the market opens on Thursday, March 13, 2025. Management will host a conference call to discuss results at 8:30 a.m. ET that same day, followed by a question and answer session for the investment community. To participate via telephone, please register in advance at this link: https://register.vevent.com/register/BI238526a995aa4b8c845f1bacc37fb5ec. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the...

– Sets Date for Fourth Quarter 2024 Earnings Release and Conference Call – BRANFORD, Conn., March 06, 2025 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) (the “Company”) announced today that its board of directors authorized and declared a quarterly dividend of $0.05 per common share to be paid to shareholders of record as of the close of trading on the NYSE American on March 17, 2025. The dividend is payable on March 31, 2025. The Company expects to release its fourth quarter 2024 financial results before market open on Thursday, March 27, 2025. A webcast and conference call to discuss the results will be held on Thursday, March 27, 2025, at 8:00 a.m. Eastern Time. Webcast:A webcast of the conference call will be available on the Investors section of the Company’s website www.sachemcapitalcorp.com. To...